세계의 생물학적 및 의료용 영상 시약 시장

The global market for biological and medical imaging reagents is estimated to grow from $26.6 billion in 2025 and forecast to reach $40.1 billion by the end of 2030, at a compound annual growth rate (CAGR) of 8.6% from 2025 to 2030.

The North American market for biological and medical imaging reagents is estimated to grow from $11.3 billion in 2025 and forecast to reach $17.4 billion by the end of 2030, at a CAGR of 9.0% from 2025 to 2030.

The Asia-Pacific market for biological and medical imaging reagents is estimated to grow from $5.5 billion in 2025 and forecast to reach $8.6 billion by the end of 2030, at a CAGR of 9.8% from 2025 to 2030.

Report Scope

The report provides an overview of the global biological and medical imaging reagent market and analyzes market trends. It includes global revenue ($ millions) using 2024 as the base year, and the forecast from 2025 through 2030. The market is segmented based on type, modality, technology, application end user, and region. The regions covered in this study include North America, Europe, Asia-Pacific, the Middle East and Africa (MEA), and South America, focusing on major countries in these regions.

The report focuses on the significant driving trends and emerging technologies that influence the market and vendor landscape. It analyzes environmental, social and corporate governance (ESG) developments and discusses patents and emerging technologies related to the market.

The report concludes with an analysis of the competitive landscape, providing the ranking/share of key global biological and medical imaging reagent companies. It also has a dedicated section of company profiles covering the profiles of leading companies in the market.

Report Includes

• 109 data tables and 68 additional tables
• An overview of the global market for biological and medical imaging reagents
• Analyses of the global market trends, with data from 2022-2024, estimates for 2025, and projections of compound annual growth rates (CAGRs) through 2030
• Evaluation of the current market size and revenue growth prospects specific to the biologic and medical imaging reagents, accompanied by a market share analysis by product type, modality, technology, application, end use, and region
• A look at classifications, comparisons, advantages, and disadvantages of these types of diagnostic methods, and analysis of current and future demand in the global biologic and medical imaging reagents industry, along with a detailed analysis of the competitive environment, market regulations and reimbursement practices
• A relevant patent analysis with emphasis on emerging technologies and new developments
• A discussion on ESG challenges and practices of the industry
• Market share analysis of the key companies of the industry and coverage of their proprietary technologies, strategic alliances, and other key market strategies
• Company profiles of the leading market players, including GE HealthCare, Thermo Fisher Scientific Inc., Siemens Healthineers AG, Bayer AG and Becton, Dickinson and Co. (BD)

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of the Report
• Market Summary
• Market Dynamics and Growth Factors
• Emerging Technologies
• Segmental Analysis
• Regional Analysis
• Conclusion

Chapter 2 Market Overview

• Overview
• Forces Driving Industry Growth
• Porter's Five Forces Analysis
• Potential for New Entrants (Moderate to High)
• Bargaining Power of Suppliers (Moderate)
• Bargaining Power of Buyers (Moderate)
• Threat of Substitutes (Low to Moderate)
• Industry Competition (High)
• Macroeconomic Factors Analysis
• Demand for Theranostics
• Image-based Invasive and Noninvasive Procedures
• Prevalence of Chronic Diseases and Rising Investments
• Drug Discovery and Other R&D Activities
• Development of Multifunctional Reagent Capabilities
• Replacement of Toxic, Hazardous Detection Reagents with Safer Reagents
• VC Investment
• Impact of U.S. Tariff

Chapter 3 Market Dynamics

• Overview
• Market Drivers
• Increasing Investments in R&D
• Growing Prevalence of Chronic Diseases
• Rising Adoption of Theranostics and Personalized Medicine
• Replacement of Toxic Reagents with Safer Alternatives
• Market Restraints
• High Development and Commercialization Costs
• Regulatory and Reimbursement Challenges
• Market Opportunities
• Integration of AI in Biologics R&D and Medical Imaging Reagents
• Emergence of Multifunctional Imaging Reagents
• Market Challenges
• Safety Concerns
• Short Shelf Life and Stability Issues

Chapter 4 Regulatory Landscape

• Regulatory Approval Process, by Select Country/Region
• U.S.
• European Union
• Asia-Pacific

Chapter 5 Emerging Technologies and Developments

• Key Takeaways
• Nanoparticles
• Next-Generation Imaging Reagents for Single-Cell and Proteomic Applications
• AI and ML in Biological and Medical Imaging Reagents
• Innovative Lateral Flow Assays Enhanced by NIR Technology
• Fluorochromes and Hybrid Targeting Platforms
• Emerging Radiotracers Enhancing Diagnostic Accuracy in Oncology
• Patent Analysis
• Key Findings

Chapter 6 Market Segment Analysis

• Segmentation Breakdown
• Market Analysis by Product Type
• Key Takeaways
• Contrast Reagents
• Radioactive Reagents
• Optical Reagents
• Market Analysis by Modality
• Key Takeaways
• Optical Imaging Reagents
• X-ray/CT Reagents
• Nuclear Imaging Reagents
• MRI Imaging Reagents
• Multimodal Imaging Reagents
• Ultrasound Imaging Reagents
• Market Analysis by Technology
• Key Takeaways
• Quantum Dots
• Radiopharmaceuticals
• Fluorescent Proteins
• Fluorescent Dyes and Probes
• Nanoparticles
• Market Analysis by Application
• Key Takeaways
• In Vivo Imaging Reagents
• In Vitro Imaging Reagents
• Market Analysis by End Use
• Key Takeaways
• Diagnostics
• R&D
• Geographic Breakdown
• Market Analysis by Region
• Key Takeaways
• North America
• Europe
• Asia-Pacific
• South America
• Middle East and Africa

Chapter 7 Competitive Intelligence

• Key Takeaways
• Global Market Shares of Leading Companies
• Key Developments and Strategies
• Partnerships and Collaborations
• Acquisitions
• Business Expansions
• Product Launches and FDA Approvals

Chapter 8 Sustainability in Biological and Medical Imaging Reagents Market: ESG Perspective

• Introduction to ESG
• Steps Toward Sustainable Use of Biologics and Medical Imaging Reagents
• Major Manufacturers: ESG Efforts
• ESG Risk Ratings
• Concluding Remarks from BCC

Chapter 9 Appendix

• Methodology
• Abbreviations
• Sources
• Company Profiles
• AGILENT TECHNOLOGIES INC.
• ALTONA DIAGNOSTICS GMBH
• ANALYTIK JENA GMBH+CO. KG.
• BAYER AG
• BD
• BIO-RAD LABORATORIES INC.
• DANAHER CORP.
• F. HOFFMANN-LA ROCHE LTD.
• GE HEALTHCARE
• MERCK KGAA
• PROMEGA CORP.
• QIAGEN
• REVVITY
• SIEMENS HEALTHINEERS AG
• THERMO FISHER SCIENTIFIC INC.
• Few Emerging Start-ups/Market Disruptors